Ortoli Rosenstadt LLP Represents Q BioMed Inc. In New $30M Investment From Aedesius Holdings Ltd.
Up Front Investment of up to $20M with an optional $10M in 6-month warrants.
NEW YORK, May 11, 2021 /PRNewswire/ -- Ortoli Rosenstadt LLP, a New York full-service international law firm, today announced that it represented Q BioMed Inc., a biotech acceleration and commercial stage company, in a signed a securities purchase agreement ("Transaction") with Aedesius Holdings Ltd, a privately owned United Kingdom based healthcare and technology aggregator.
The agreement gives Aedesius the opportunity to buy approximately 43% of the outstanding shares for an aggregate of $30,000,000. The Transaction is structured as an initial investment of $5,000,000 with an additional $15,000,000 by September 30, 2021 with 50% warrant coverage allowing an additional $10,000,000 investment within 180 days. The Unit Price is set at $1.25 per share, a 30% premium to today's closing price. The investor is expected to ultimately take a seat on the Board.
Partner William Rosenstadt handled the transaction for Ortoli Rosenstadt LLP.
About Ortoli Rosenstadt LLP
Founded in 2006, Ortoli Rosenstadt LLP is a New York-based law firm representing global clients. The firm provides cutting-edge, solution-oriented legal advice to its clients in a wide variety of practice areas, including corporate & securities, mergers and acquisitions, real estate, global mobility and employment, intellectual property, and litigation.
SOURCE Ortoli Rosenstadt LLP
Related Links
Explore
More news releases in similar topics